Showing results (171-180 of 410) with videos related to

Sort By:
Pageof 41
Tissue Antigens|April 29, 1998
HFE codon 63/282 (H63D/C282Y) dimorphism in German patients with genetic hemochromatosisR Gottschalk, C Seidl, T Löffler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1998
High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemiaT Karakas, U Maurer, E Weidmann, et al.
Cancer Genetics and Cytogenetics|March 1, 1995
12q13, a new recurrent breakpoint in acute non-lymphoblastic leukemiaM M Seyger, J Ritterbach, U Creutzig, et al.
Leukemia|August 19, 2005
Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemiaT Lehrnbecher, T Bernig, M Hanisch, et al.
Klinische Padiatrie|September 3, 1999
[Antiinfectious prophylaxis in pediatric oncology. Work group "Quality Assurance" of Society for Pediatric Oncology and Hematology (GPOH)]U B Graubner, J Boos, U Creutzig, et al.
British Journal of Haematology|October 4, 2005
Potentiation of in vitro ara-C cytotoxicity by ribonucleotide reductase inhibitors, cyclin-dependent kinase modulators and the DNA repair inhibitor aphidicolin in paediatric acute myeloid leukaemiaI Hubeek, G J Peters, A J F Broekhuizen, et al.
Annals of Hematology|May 1, 1991
Effect of recombinant human transforming growth factor beta and tumor necrosis factor alpha on bone marrow progenitor cells of HIV-infected personsR G Geissler, O G Ottmann, M Eder, et al.
Diabetologia|January 22, 2005
Antioxidative treatment prevents activation of death-receptor- and mitochondrion-dependent apoptosis in the hearts of diabetic ratsJ Bojunga, D Nowak, P S Mitrou, et al.
Leukemia & Lymphoma|January 1, 1994
Immunophenotypic features of childhood and adult acute lymphoblastic leukemia (ALL): experience of the German Multicentre Trials ALL-BFM and GMALLW D Ludwig, A Reiter, H Löffler, et al.
Onkologie|February 1, 1990
Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine-arabinoside in the treatment of patients with myelodysplastic syndromes. A phase II studyK Höffken, F Overkamp, J Stirbu, et al.
Pageof 41